Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

162345

Sigma-Aldrich

3-(3,4-Dimethoxyphenyl)propionic acid

99%

Synonym(s):

3,4-Dimethoxyhydrocinnamic acid

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
(CH3O)2C6H3CH2CH2CO2H
CAS Number:
2107-70-2
Molecular Weight:
210.23
Beilstein:
2696272
EC Number:
218-288-3
MDL number:
MFCD00002774
UNSPSC Code:
12352100
PubChem Substance ID:
24849979
NACRES:
NA.22

Assay

99%

form

solid

mp

96-97 °C (lit.)

functional group

carboxylic acid

SMILES string

COc1ccc(CCC(O)=O)cc1OC

InChI

1S/C11H14O4/c1-14-9-5-3-8(4-6-11(12)13)7-10(9)15-2/h3,5,7H,4,6H2,1-2H3,(H,12,13)

InChI key

LHHKQWQTBCTDQM-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

3-(3,4-Dimethoxyphenyl)propionic acid (3,4-Dimethoxyhydrocinnamic acid) forms complex with copper (II)[1].

Application

3-(3,4-Dimethoxyphenyl)propionic acid was used in screening of short-chain fatty acid derivatives for the ability to induce γ globin gene expression in reporter assays and erythropoiesis in vivo[2].

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
S44998
S43231
12931JE
S37419
71126_

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Metal-cinnamic acids interactions. Part IV. Synthesis, study and antimicrobial activity of copper (II) complexes of 3, 4-dimethoxyhydrocinnamic acid.
Zoroddu MA and Berardi E.
Transition Met. Chem. (London), 14(4), 269-272 (1989)
Betty S Pace et al.
Blood, 100(13), 4640-4648 (2002-10-24)
Orally bioactive compounds that induce gamma globin gene expression at tolerable doses are needed for optimal treatment of the beta-hemoglobinopathies. Short-chain fatty acids (SCFAs) of 2 to 6 carbons in length induce gamma globin expression in animal models, and butyrate

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service